Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

AZ Spin-Out Entasis Appoints Scientific And Clinical Advisory Board

This article was originally published in Scrip

Executive Summary

Entasis Therapeutics, a company focused on bacterial infections, has formed its scientific and clinical advisory board, appointing Paul G. Ambrose, Karen Bush, Stanley A. Nasraway, Mark Noe and Brad Spellberg.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register